期刊文献+

HIF-1α、OPN及c-Met在胆管癌中的表达及其临床意义 被引量:1

Expressions of HIF-1α,OPN and c-Met in Cholangiocarcinoma and Their Significance
原文传递
导出
摘要 [目的]探讨缺氧诱导因子-1α(HIF-1α)、骨桥蛋白(OPN)及c-Met在胆管癌组织中的表达及其临床意义。[方法]采用免疫组化SP法检测HIF-1α、OPN及c-Met在56例胆管癌、30例癌旁正常胆管组织中的表达情况,并分析其与临床病理特征关系及三者的相关性。[结果 ]HIF-1α、OPN及c-Met在胆管癌组织中的表达均明显高于癌旁正常胆管组织,并且在胆管癌组织中表达与患者年龄、性别、肿瘤大小、肿瘤部位、分化程度无相关性(P>0.05),而与肿瘤分期、有无淋巴结转移有关(P<0.05)。HIF-1α、OPN及c-Met在胆管癌组织样本中表达均呈正相关(P<0.05)。[结论]HIF-1α、OPN及c-Met在胆管癌组织中高表达,与肿瘤侵袭转移关系密切。 [Objective] To explore the expressions of HIF-1α,OPN and c-Met in cholangiocarcinoma and their significance.[Methods] The expression of HIF-1α,OPN and c-Met in cholangiocarcinoma issue samples of 56 cases and bile duct tissue samples adjacent to carcinoma of 30 cases were detected by immunohistochemical SP methods.The relationship with clinical pathological features and their correlation were analyzed.[Results ] The expression of HIF-1α,OPN and c-Met in cholangiocarcinoma were significantly higher than those in bile duct tissue adjacent to carcinoma.The strong positive expression in cholangiocarcinoma wasn 't related with age,sex,tumor size,tumor location and differentiation degree,while was related with tumor stage and lymph node metastasis(P〈0.05).There were positive correlations between HIF-1α,OPN and c-Met expression in cholangiocarcinoma(P〈0.05).[Conclusion] The expressions of HIF-1α,OPN and c-Met are higher in cholangiocarcinoma,and are closely associated with tumor invasion and metastasis.
机构地区 保定市第一医院
出处 《肿瘤学杂志》 CAS 2016年第8期643-647,共5页 Journal of Chinese Oncology
关键词 胆管肿瘤 淋巴结转移 缺氧诱导因子-1Α 骨桥蛋白 C-MET cholangiocarcinoma lymph node metastasis hypoxia induced factor-1α osteopontin c-Met
  • 相关文献

参考文献13

二级参考文献255

  • 1张东涛,袁静,杨力,郭新宁,郝志明,韩者艺,吴开春,樊代明.骨桥蛋白在胃癌中的表达及与胃癌侵袭转移的关系[J].中华肿瘤杂志,2005,27(3):167-169. 被引量:18
  • 2Okuda K. Hepatocellular carcinoma. J Hepatol 2000; 32: 225-237.
  • 3Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001; 94:153-156.
  • 4Wong CM, Ng IO. Molecular pathogenesis of hepatocellular carcinoma. Liver Int 2008; 28:160-174.
  • 5Bosch FX, Ribes J, Cleries R, Diaz M. Epidemiology of hepa- tocellular carcinoma. Clin Liver Dis 2005; 9: 191-211, v.
  • 6EI-Serag HB, Rudolph KL. Hepatocellular carcinoma: epi- demiology and molecular carcinogenesis. Gastroenterology 2007; 132:2557-2576.
  • 7Gotoh M, Sakamoto M, Kanetaka K, Chuuma M, Hirohashi S. Overexpression of osteopontin in hepatocellular carci- noma. Pathol Int 2002; 52:19-24.
  • 8Xie H, Song J, Du R, Liu K, Wang J, Tang H, Bai F, Liang J, Lin T, Liu J, Fan D. Prognostic significance of osteopontin in hepatitis B virus-related hepatocellular carcinoma. Dig Liver Dis 2007; 39:167-172.
  • 9Ye QH, Qin LX, Forgues M, He P, Kim JW, Peng AC, Simon R, Li Y, Robles AI, Chen Y, Ma ZC, Wu ZQ, Ye SL, Liu YK, Tang ZY, Wang XW. Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning. Nat Med 2003; 9: 416-423.
  • 10Sun BS, Dong QZ, Ye QH, Sun HJ, Jia HL, Zhu XQ, Liu DY, Chen J, Xue Q, Zhou HJ, Ren N, Qin LX. Lentiviral-mediat- ed miRNA against osteopontin suppresses tumor growth and metastasis of human hepatocellular carcinoma. Hepatol- ogy 2008; 48:1834-1842.

共引文献75

同被引文献8

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部